NO324680B1 - Mikrogranuler, som inneholder diltiazem som aktivt prinsipp, for vedvarende frigjoring og gelatinkapsler som omfatter mikrogranulene. - Google Patents

Mikrogranuler, som inneholder diltiazem som aktivt prinsipp, for vedvarende frigjoring og gelatinkapsler som omfatter mikrogranulene. Download PDF

Info

Publication number
NO324680B1
NO324680B1 NO19982738A NO982738A NO324680B1 NO 324680 B1 NO324680 B1 NO 324680B1 NO 19982738 A NO19982738 A NO 19982738A NO 982738 A NO982738 A NO 982738A NO 324680 B1 NO324680 B1 NO 324680B1
Authority
NO
Norway
Prior art keywords
layer
microgranules according
microgranules
active principle
surfactant
Prior art date
Application number
NO19982738A
Other languages
English (en)
Norwegian (no)
Other versions
NO982738L (no
NO982738D0 (no
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO324680(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of NO982738D0 publication Critical patent/NO982738D0/no
Publication of NO982738L publication Critical patent/NO982738L/no
Publication of NO324680B1 publication Critical patent/NO324680B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO19982738A 1995-12-22 1998-06-12 Mikrogranuler, som inneholder diltiazem som aktivt prinsipp, for vedvarende frigjoring og gelatinkapsler som omfatter mikrogranulene. NO324680B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (3)

Publication Number Publication Date
NO982738D0 NO982738D0 (no) 1998-06-12
NO982738L NO982738L (no) 1998-08-21
NO324680B1 true NO324680B1 (no) 2007-12-03

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982738A NO324680B1 (no) 1995-12-22 1998-06-12 Mikrogranuler, som inneholder diltiazem som aktivt prinsipp, for vedvarende frigjoring og gelatinkapsler som omfatter mikrogranulene.

Country Status (27)

Country Link
US (3) US6228395B1 (es)
EP (1) EP0868184B1 (es)
JP (1) JP2000506500A (es)
KR (1) KR100354054B1 (es)
CN (1) CN1145488C (es)
AR (1) AR004410A1 (es)
AT (1) ATE238798T1 (es)
AU (1) AU721949B2 (es)
BG (1) BG63770B1 (es)
BR (1) BR9612225A (es)
CA (1) CA2242224C (es)
DE (1) DE69627880T2 (es)
DK (1) DK0868184T3 (es)
EA (1) EA001721B1 (es)
EE (1) EE04045B1 (es)
ES (1) ES2198505T3 (es)
FR (1) FR2742660B1 (es)
GE (1) GEP20022629B (es)
HK (1) HK1018400A1 (es)
HU (1) HU224214B1 (es)
IL (1) IL125047A (es)
NO (1) NO324680B1 (es)
NZ (1) NZ324739A (es)
PL (1) PL186621B1 (es)
PT (1) PT868184E (es)
WO (1) WO1997023219A1 (es)
ZA (1) ZA9610776B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
EP1689373B1 (en) * 2003-10-10 2019-04-03 Ethypharm Sustained-release microgranules containing ginkgo biloba extract and the process for manufacturing these
JPWO2005065715A1 (ja) * 2003-12-25 2007-07-26 武田薬品工業株式会社 造粒性改善方法
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
ES2385612T3 (es) * 2006-06-19 2012-07-27 Alpharma Pharmaceuticals, Llc Composiciones farmacéuticas
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
ES2198505T3 (es) 2004-02-01
PT868184E (pt) 2003-09-30
BR9612225A (pt) 1999-07-13
DE69627880D1 (de) 2003-06-05
JP2000506500A (ja) 2000-05-30
HUP9904129A2 (hu) 2000-04-28
CN1207681A (zh) 1999-02-10
ATE238798T1 (de) 2003-05-15
HUP9904129A3 (en) 2000-11-28
DK0868184T3 (da) 2003-08-25
KR100354054B1 (ko) 2003-02-14
HU224214B1 (hu) 2005-06-28
NZ324739A (en) 2000-01-28
EA199800593A1 (ru) 1998-12-24
EE9800197A (et) 1998-12-15
FR2742660A1 (fr) 1997-06-27
GEP20022629B (en) 2002-02-25
CA2242224A1 (fr) 1997-07-03
IL125047A0 (en) 1999-01-26
DE69627880T2 (de) 2004-03-11
EE04045B1 (et) 2003-06-16
EA001721B1 (ru) 2001-08-27
PL327567A1 (en) 1998-12-21
US20020182253A1 (en) 2002-12-05
AR004410A1 (es) 1998-11-04
US6660296B2 (en) 2003-12-09
AU721949B2 (en) 2000-07-20
US6228395B1 (en) 2001-05-08
ZA9610776B (en) 1997-06-30
CA2242224C (fr) 2004-01-13
NO982738L (no) 1998-08-21
CN1145488C (zh) 2004-04-14
KR19990076717A (ko) 1999-10-15
WO1997023219A1 (fr) 1997-07-03
HK1018400A1 (en) 1999-12-24
EP0868184B1 (fr) 2003-05-02
EP0868184A1 (fr) 1998-10-07
IL125047A (en) 2003-05-29
BG102555A (en) 1999-02-26
AU1198397A (en) 1997-07-17
PL186621B1 (pl) 2004-02-27
NO982738D0 (no) 1998-06-12
BG63770B1 (bg) 2002-12-29
FR2742660B1 (fr) 1998-04-03
US6383516B1 (en) 2002-05-07

Similar Documents

Publication Publication Date Title
NO324680B1 (no) Mikrogranuler, som inneholder diltiazem som aktivt prinsipp, for vedvarende frigjoring og gelatinkapsler som omfatter mikrogranulene.
EP1051174B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
US7067151B1 (en) Controlled absorption diltiazem pharmaceutical formulation
US4894240A (en) Controlled absorption diltiazem formulation for once-daily administration
CA2480826A1 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
PT89276B (pt) Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada constituida por microgranulos revestidos com etilcelulose e eudragit rs (resina acrilica, polimerizado de esteres dos acidos acrilico e metacrilico)
CA2500390A1 (en) Compositions having an inner core and at least two surrounding layers
CA2493453A1 (fr) Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
CA2476496A1 (en) Controlled release dosage forms
MX2008001282A (es) Tratamiento con bloqueadores del canal del calcio de dihidropiridina y acidos grasos omega-3 y un producto de combinacion de los mismos.
HUP0101178A2 (hu) Gyomorfekély elleni 2-{[(2-piridinil)-metil]-szulfinil}-benzimidazolt tartalmazó gyógyszerkészítmény és eljárás gyógyszerkészítmény előállítására
CA2473200A1 (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
CA2497197A1 (en) A tooth whitening product comprising a film and whitening agent and process for making it
CA2377605A1 (en) Stable benzimidazole formulation
CA2373972C (fr) Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
EP1627631A3 (fr) Microgranules de sulfate de morphine, procédé de préparation et composition les contenant
JP2004505034A (ja) 制御された放出のシグモイドパターンを示すエレトリプタンの粒状組成物
Di Minno et al. Polyunsaturated fatty acids, thrombosis and vascular disease
CA2781199A1 (en) Suppository comprising pantoprazole
CA2520020A1 (en) Venlafaxine compositions comprising pellets with double layer coating
CA2280980A1 (fr) Composition pharmaceutique pour la liberation programmee de dexfenfluramine
Griffo et al. n-3 fatty acids and coronary artery disease
HRP20131049T1 (hr) Aktivni metabolit antagonista trombinskog receptora

Legal Events

Date Code Title Description
MK1K Patent expired